Couverture de Business Of Biotech

Business Of Biotech

Business Of Biotech

De : Ben Comer
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.

© 2025 Business Of Biotech
Economie Management Management et direction Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead
      Jan 5 2026

      We love to hear from our listeners. Send us a message.

      This week's special holiday episode of the Business of Biotech brings seven chief editors from the Life Science Connect family together to talk about the life sciences industry topics, trips, and reporting that mattered most in 2025, and what each editor has planned for 2026. From the RNA, cell, and gene therapy space to small molecule manufacturing, bioprocessing, drug discovery, and outsourcing, the editors weigh in on key industry trends, new developments, and policy surprises from their respective coverage areas. Topics include biotech funding dynamics, FDA leadership, China's growing role, favorite holiday movies, and much, much more. Special thanks to Tyler Menichiello and the Better Biopharma podcast for hosting this roundtable discussion. Happy New Year!

      Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.

      Subscribe to our monthly Business of Biotech newsletter.

      Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.com

      Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/


      Afficher plus Afficher moins
      1 h et 21 min
    • Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos
      Dec 29 2025

      We love to hear from our listeners. Send us a message.

      On this week's episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks about his experiences building cell therapy spinouts from FujiFilm Cellular Dynamics, learning from big pharma decision-making processes, and dosing the first patient with Kenai's allogeneic neuron replacement cell therapy for Parkinson's disease. Nick also talks about funding an early-stage cell therapy company and forging key manufacturing and therapy administration partnerships.

      Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.

      Subscribe to our monthly Business of Biotech newsletter.

      Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.com

      Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/


      Afficher plus Afficher moins
      47 min
    • Modernizing Clinical Trial Operations With Merck's Jennifer Sheller
      Dec 22 2025

      We love to hear from our listeners. Send us a message.

      On this week's episode of the Business of Biotech, Jennifer Sheller, SVP and Head of Global Clinical Trial Operations at Merck talks about simplifying trial protocols and what she likes about Merck's hybrid functional service provider model for conducting trials in over 60 countries. Jennifer shares her experiences integrating Merck's acquisitions without breaking studies or losing people, using new technology to improve trial operations, and co-designing studies with trial sites for agility and speed.

      Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.

      Subscribe to our monthly Business of Biotech newsletter.

      Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.com

      Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/


      Afficher plus Afficher moins
      56 min
    Aucun commentaire pour le moment